Multi-source vegetable outer vesicle composition as well as preparation method and application thereof

The preparation method of multi-source vegetable exovesicle composition solves the problems of single active ingredients and difficult preparation of plant exovesicles, and realizes targeted regulation and efficient drug delivery to adipocytes. It can be applied to the prevention or treatment of metabolic diseases, especially obesity and non-alcoholic fatty liver disease.

CN120899869APending Publication Date: 2025-11-07NANJING DRUM TOWER HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511123381.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-08-12
Publication Date
2025-11-07

AI Technical Summary

Technical Problem

Existing plant exovesicles have limited active ingredients, insufficient metabolic regulation, and are difficult to prepare on a large scale. Furthermore, they have low cross-cell barrier delivery efficiency, low bioavailability and weak targeting of traditional drug delivery methods, and pose immunogenicity risks and ethical controversies.

Method used

A multi-source vegetable exovesicle composition was developed, consisting of exovesicles extracted from spinach leaves, ginger rhizomes, broccoli buds, bitter melon fruits, and celery stalks. These exovesicles were prepared through low-temperature homogenization, differential centrifugation, and ultrafiltration purification. Combined with hyaluronic acid hydrogel delivery, this method achieves targeted and dual-pathway regulation of adipocyte lipolysis and oxidative stress.

Benefits of technology

It significantly enhances metabolic regulation and antioxidant efficacy, achieves dual-pathway targeted regulation of adipocyte lipolysis and oxidative stress, supports oral and subcutaneous administration, improves metabolic diseases such as obesity, type II diabetes and non-alcoholic fatty liver disease, and meets the needs of large-scale production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120899869A_ABST
    Figure CN120899869A_ABST
Patent Text Reader

Abstract

The invention discloses a multi-source vegetable outer vesicle composition as well as a preparation method and application thereof. The multi-source vegetable outer vesicle composition is prepared from outer vesicles extracted from spinach leaves, ginger tubers, broccoli buds, bitter gourd fruits and celery stems. The spinach leaves, the ginger tubers, the broccoli flower buds, the bitter gourd fruits and the celery stems are mixed according to the fresh weight ratio of (3-5): (1-2): (2-3): (1-1.5): (2-4), and low-temperature homogenization, centrifugation and ultrafiltration purification are performed to obtain the spinach-ginger-containing beverage. The particle size of the multisource vegetable outer vesicle composition is 100-200 nm, and the multisource vegetable outer vesicle composition comprises transmembrane protein TET8 and membrane anchoring protein ANNEXIN, and further comprises active ingredients of miR159a, miR166a, quercetin and kaempferol. The outer vesicle can target a PPAR gamma / FAS pathway and regulate and control lipolysis and metabolism reprogramming of fat cells; meanwhile, an Nrf2 pathway is activated, free radicals are removed, oxidative stress injury is inhibited, and metabolic diseases such as obesity, type II diabetes mellitus and non-alcoholic fatty liver disease can be effectively improved.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present application belongs to the technical field of biological medicine, and particularly relates to an exovesicle composition extracted from a specific vegetable combination, a preparation method thereof, and application thereof in preventing or treating metabolic diseases such as obesity, diabetes, non-alcoholic fatty liver and the like. BACKGROUND

[0002] Obesity and related metabolic syndrome have become a global health burden, and its pathological process involves adipose tissue dysfunction, lipid metabolism disorder and chronic inflammatory reaction. Current treatment strategies based on animal-derived exosomes have immunogenicity risks and ethical controversies, while single plant exovesicles have the advantage of biocompatibility, but are limited by the single nature of active ingredients and insufficient metabolic regulation efficacy, especially the lack of synergistic intervention ability on the lipolysis function and oxidative stress of mature adipocytes. In addition, in the preparation process of the existing plant exovesicles, polyphenols are prone to degradation during mechanical crushing, the delivery efficiency across the cell barrier is low, and it is difficult to maintain the stability of miRNA. Traditional drug delivery methods also face challenges such as low bioavailability and weak targeting, which restrict the application of exovesicles in the treatment of metabolic diseases. Therefore, it is urgent to develop a multi-source plant exovesicle composition that can be prepared on a large scale and has controllable active ingredients, so as to break through the technical bottlenecks of the existing technology through a synergistic regulation mechanism. SUMMARY

[0003] The technical problem to be solved by the present application is that the active ingredients of the plant exovesicles are single, the metabolic regulation efficacy is insufficient, and the large-scale preparation is difficult in the prior art. The present application provides a multi-source vegetable exovesicle composition, a preparation method thereof and application thereof.

[0004] To achieve the above-mentioned purpose, the technical solutions adopted by the present application are as follows: A multi-source vegetable exovesicle composition is composed of exovesicles extracted from spinach leaves, ginger tubers, broccoli flower buds, bitter gourd fruits and celery stems; the spinach leaves, ginger tubers, broccoli flower buds, bitter gourd fruits and celery stems are mixed in a fresh weight ratio of (3-5):(1-2):(2-3):(1-1.5):(2-4), and are prepared by low-temperature homogenization, centrifugation and ultrafiltration purification.

[0005] Preferably, the particle size of the multi-source vegetable exovesicle composition is detected by dynamic light scattering method, and the range is 100-200 nm.

[0006] Specifically, the multi-source vegetable exovesicle composition uses Western blot to verify its protein markers, including heat shock protein HSP70 and membrane-anchored protein Annexin; high-throughput sequencing is used to detect and analyze its active miRNA components, and it is confirmed to contain miR159a, miR166a and the like.

[0007] Further, the present application also provides a preparation method of the multi-source vegetable exosome composition, comprising the following steps: S1, vegetable raw material treatment: weigh fresh vegetable raw materials, mix after washing; use a tissue homogenizer to homogenize and crush the mixed raw materials 2-3 times; S2, separation and purification of multi-component exosomes: further purify the above mixed homogenate by differential centrifugation or ultrafiltration centrifugation; concentrate, and filter through a 0.22 μm filter to obtain the product.

[0008] Specifically, in step S1, the mixed raw materials are homogenized and crushed at a speed of 8000-12000 rpm using a tissue homogenizer at 0-4 ℃.

[0009] Specifically, in step S2, the differential centrifugation step is as follows: first, remove the residue by centrifugation at 3000g for 15 minutes, then remove the large particle impurities by centrifugation at 10000g for 30 minutes, and finally collect the exosome precipitate by ultracentrifugation at 110000g for 90 minutes.

[0010] Specifically, in step S2, the ultrafiltration centrifugation step is as follows: sequentially filter the homogenate through 10 μm, 0.8 μm, and 0.22 μm filter membranes, and then concentrate it through a 100 kDa molecular weight cut-off ultrafiltration tube.

[0011] Further, the present application also claims the use of the above multi-source vegetable exosome composition in the preparation of a medicament for preventing and / or treating metabolic diseases.

[0012] Specifically, the metabolic disease is any one of obesity, type II diabetes, and non-alcoholic fatty liver.

[0013] Preferably, the multi-source vegetable exosome composition is administered by subcutaneous injection or oral administration of a hyaluronic acid hydrogel, and the concentration of the exosomes in the hydrogel is 200-400 μg / ml. The effective dose of the medicament ranges from 50 to 200 μg exosome protein / kg body weight / time, and the administration is performed 3 times a week for 4-8 weeks. Advantages

[0014] (1) The multi-source vegetable exosome composition of the present application significantly enhances metabolic regulation and antioxidant efficacy. The exosomes can target the PPARγ / FAS pathway, regulate lipolysis and metabolic reprogramming of adipocytes, activate the Nrf2 pathway, scavenge free radicals, and inhibit oxidative stress damage. By targeting the core links of adipocyte lipolysis and oxidative stress through the double pathways, a clear treatment mechanism is achieved.

[0015] (2) The vegetable exovesicles of the present invention can be encapsulated in a biodegradable hydrogel to prepare an oral or injectable hydrogel drug delivery system. Furthermore, the composition can also be encapsulated in a hyaluronic acid hydrogel to form an oral or injectable drug delivery system. The hydrogel carrying the exovesicles can achieve the enrichment of subcutaneous fat cells, and the concentration of the exovesicles in the hydrogel is 200~400 μg / ml.

[0016] (3) The multi-source vegetable exovesicle composition of the present invention supports both oral and injectable routes, greatly expanding the clinical application scenarios. Through oral administration or subcutaneous injection, it can effectively improve the pathological process of metabolic diseases such as obesity, type II diabetes, and non-alcoholic fatty liver.

[0017] (4) The process of the present invention, through the adaptation of differential centrifugation and ultrafiltration dual paths, can not only meet the needs of large-scale production, but also effectively protect the heat-sensitive active ingredients. Attached Figure Description

[0018] The present invention will be further described in detail below with reference to the accompanying drawings and specific embodiments, and the advantages of the present invention in the above and / or other aspects will become clearer.

[0019] Figure 1 A schematic diagram illustrating the preparation process of the vegetable-derived exovesicle composition provided by the present invention.

[0020] Figure 2 This is a particle size distribution diagram of the vegetable-derived exovesicle composition in Example 1.

[0021] Figure 3 This is a transmission electron microscope image of the vegetable-derived exovesicles in Example 1.

[0022] Figure 4 This is a Western blotting image of HSP70 and Annexin proteins in vegetable-derived exovesicles from Example 1.

[0023] Figure 5 The graph shows the top 10 miRNA expression levels in vegetable-derived exovesicles from Example 1.

[0024] Figure 6 Image showing the staining of lipid droplets in adipocytes by vegetable-derived exovesicle compositions.

[0025] Figure 7 The curve showing the change in body weight in obese mice treated with vegetable-derived exovesicle compositions.

[0026] Figure 8 Image of liver H&E staining in obese mice as a result of treatment with vegetable-derived exovesicle compositions. Detailed Implementation

[0027] The application can be better understood in accordance with the following examples. Example 1

[0028] Preparation and characterization of the vegetable-derived exovesicle composition: 1. Preparation and characterization of the vegetable-derived exovesicle composition: Fresh vegetable raw materials were weighed according to the mass ratio of spinach leaves, ginger tubers, broccoli florets, bitter gourd fruits, and celery stems as 4:1.5:2.5:1.2:3, and mixed after washing. The mixed raw materials were homogenized and broken twice at a speed of 10,000 rpm for 1 minute each time under the condition of 4 ℃, with ice bath cooling in between, to ensure that the raw materials were fully broken and the cell contents were released. The specific process is shown in Figure 1 .

[0029] 2. Separation and purification of the vegetable exovesicle composition: The above mixed homogenate was separated and purified by differential centrifugation. The specific steps are as follows: first, remove the residue by centrifugation at 3000 g for 15 minutes; then remove the large particle impurities by centrifugation at 10,000 g for 30 minutes; finally, collect the exovesicle precipitate by ultracentrifugation at 110,000 g for 90 minutes. Resuspend the precipitate with sterile PBS, and then filter-sterilize it through a 0.22 μm filter membrane to obtain the purified exovesicle solution.

[0030] 3. Physicochemical characterization of the exovesicle composition: The particle size of the exovesicle was detected by dynamic light scattering method, and the results showed that the particle size range was 105.7 nm±4.58 nm, and the charge was -13.44±3.21 mV, as shown in Figure 2 . Transmission electron microscopy observation showed a typical phospholipid bilayer vesicle structure, as shown in Figure 3 .

[0031] Western blot was used to verify the protein markers, confirming the presence of heat shock protein HSP70 and membrane-anchored protein Annexin, as shown in Figure 4 . High-throughput sequencing was used to detect and analyze the active miRNA components, confirming the presence of miR159a, miR166a, etc., as shown in Figure 5 . Example 2

[0032] Regulatory effect of the vegetable-derived exovesicle composition on fat metabolism: 1. Fat cell culture and treatment: 3T3-L1 preadipocytes were selected and induced to differentiate into mature adipocytes. The prepared exovesicle composition was added to the culture medium at a concentration of 50, 100 μg / ml, and the control group was not added.

[0033] 2. Lipid droplet staining and observation: Lipid droplets in adipocytes were stained using BODIPY 493 / 503 staining method, observed under fluorescence microscope and photographed. The results showed that the exovesicle composition could significantly reduce the accumulation of lipid droplets, indicating that it had the function of promoting lipolysis of adipocytes, as shown in FIG. 2. Figure 6 Example 3

[0034] Therapeutic effect of vegetable-derived exovesicle composition on obese mice: 1. Construction of obesity model Six-week-old C57BL / 6J male mice were selected, and an obesity model was induced by high-fat diet (HFD, 60% kJ, D12492). The mice were divided into two groups: control group (fed with HFD) and treatment group (fed with HFD + exovesicle composition treatment). All mice were raised in SPF animal room, with a lighting cycle controlled at 12 hours (light) / 12 hours (dark) day-night cycle, humidity of 50-60%, and temperature of 20-22 °C.

[0035] 2. Administration method of exovesicle composition The exovesicle composition was wrapped in hyaluronic acid hydrogel to form an injectable drug delivery system. At a dose of 100 μg exovesicle protein / kg body weight / time, subcutaneous injection was administered twice a week for 8 weeks.

[0036] 3. Monitoring of body weight changes During the treatment period, the body weight of the mice was measured and recorded every week. The results showed that the body weight gain of the mice in the treatment group was significantly lower than that in the control group, indicating that the exovesicle composition could effectively inhibit the body weight gain of obese mice, as shown in FIG. 3. Figure 7 Example 4

[0037] Protective effect of vegetable-derived exovesicle composition on liver of obese mice: 1. Collection of tissue samples After the treatment, the mice were dissected, and liver tissues were taken for H&E staining. The pathological changes of liver tissues were observed under a microscope, and the results showed that the fatty degeneration and inflammatory cell infiltration in the liver tissues of the mice in the treatment group were significantly reduced, indicating that the exovesicle composition had a protective effect on the liver of obese mice.

[0038] 2. H&E staining and analysis of liver H&E staining method was used to stain liver tissue sections, and images were observed and photographed under a microscope. The results showed that the pathological damage of liver tissues of the mice in the treatment group was significantly reduced, and the liver cells were arranged more regularly, without obvious fatty degeneration and inflammatory cell infiltration, as shown in FIG. 4. Figure 8

[0039] ​​​The application provides a multi-source vegetable outer vesicle composition and a preparation method and application idea and method thereof. There are many methods and approaches to specifically realize the technical scheme. The above description is only a preferred embodiment of the application. It should be pointed out that, for ordinary skilled persons in the technical field, some improvements and refinements can be made without departing from the principle of the application, and these improvements and refinements should also be regarded as the protection scope of the application. The components not explicitly described in the embodiment can be realized by using the prior art.

Claims

1. A multi-source vegetable out vesicle composition, characterized by, The outer vesicle composition is extracted from spinach leaves, ginger rhizomes, broccoli flower buds, bitter gourd fruits and celery stems; the spinach leaves, ginger rhizomes, broccoli flower buds, bitter gourd fruits and celery stems are mixed in a fresh weight ratio of (3-5):(1-2):(2-3):(1-1.5):(2-4), and are purified by low-temperature homogenization, centrifugation and ultrafiltration.

2. The multi-source vegetable out-vesicle composition according to claim 1, characterized by, The particle size of the multi-source vegetable outer vesicle composition is 100-200 nm.

3. The multi-source vegetable out-vesicle composition according to claim 1, characterized by, The multi-source vegetable outer vesicle composition contains heat shock protein HSP70 and membrane-anchored protein Annexin, and also contains active miRNA components miR159a and miR166a.

4. The method of preparing the multi-source vegetable out-vessel vesicle composition of claim 1, characterized in that, The method comprises the following steps: S1, vegetable raw material treatment: weighing fresh vegetable raw materials, mixing after washing; using a tissue homogenizer to homogenize and crush the mixed raw materials for 2-3 times; S2, separation and purification of multi-component outer vesicles: further purifying the above mixed homogenate by differential centrifugation or ultrafiltration centrifugation; After concentration and 0.22 μm filter sterilization filtration, the product is obtained.

5. The method of preparing a multi-source vegetable out vesicle composition according to claim 4, characterized in that, In step S1, the mixed raw materials are homogenized and crushed at a speed of 8000-12000 rpm using a tissue homogenizer at 0-4 ℃.

6. The method of preparing a multi-source vegetable out vesicle composition according to claim 4, characterized in that, In step S2, the differential centrifugation step is as follows: first, remove the residue by centrifugation at 3000g for 15 minutes, then remove the large particle impurities by centrifugation at 10000g for 30 minutes, and finally collect the outer vesicle precipitate by ultracentrifugation at 110000g for 90 minutes.

7. The method of preparing a multi-source vegetable out vesicle composition according to claim 4, characterized by, In step S2, the ultrafiltration centrifugation step is as follows: the homogenate is sequentially filtered through 10 μm, 0.8 μm and 0.22 μm filter membranes, and then concentrated through a 100 kDa molecular weight cut-off ultrafiltration tube.

8. The multi-source vegetable outer vesicle composition of claim 1 for use in the preparation of a medicament for preventing and / or treating metabolic diseases.

9. Use according to claim 8, characterized in that, The metabolic disease is any one of obesity, type II diabetes and non-alcoholic fatty liver.

10. Use according to claim 8, characterized in that, The multi-source vegetable outer vesicle composition is administered by subcutaneous injection or oral administration combined with hyaluronic acid hydrogel, the concentration of the outer vesicle in the hydrogel is 200-400 μg / ml; the effective dose of the drug ranges from 50 to 200 μg of outer vesicle protein per kg of body weight per time, and the drug is administered 3 times a week for 4-8 weeks.